Technology Landscape & Monitoring – Targeted Protein Degradation
A multinational integrated biopharma multinational client had a strategic need to screen and achieve comprehensive assessments of Targeted Proteolysis technology through patent and scientific literature published, early scientific sentiments, key updates on the clinical developments in this domain, assess competitors’ activities corresponding to this technology. FutureBridge developed a collaborative framework, key opinion leaders and recommendations helped the client with Insights in terms of current development trends and future pipeline outlook. These insights were leveraged by the client to align R&D efforts in developing the overall assets portfolio. A continuous monitoring program was custom designed for the client to keep track of developments across priority assets within the targeted platform.
Case_Study1-Targeted-Protein-Degradation
